These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1485370)

  • 21. Pharmacokinetics of intravenous and rectal ketoprofen in young children.
    Kokki H; Karvinen M; Suhonen P
    Clin Pharmacokinet; 2003; 42(4):373-9. PubMed ID: 12648027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of oxycodone.
    Lugo RA; Kern SE
    J Pain Palliat Care Pharmacother; 2004; 18(4):17-30. PubMed ID: 15760805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects.
    Pöyhiä R; Seppälä T; Olkkola KT; Kalso E
    Br J Clin Pharmacol; 1992 Jun; 33(6):617-21. PubMed ID: 1389934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis.
    Anderson BJ; van Lingen RA; Hansen TG; Lin YC; Holford NH
    Anesthesiology; 2002 Jun; 96(6):1336-45. PubMed ID: 12170045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grapefruit juice enhances the exposure to oral oxycodone.
    Nieminen TH; Hagelberg NM; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
    Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):782-8. PubMed ID: 20406214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voriconazole drastically increases exposure to oral oxycodone.
    Hagelberg NM; Nieminen TH; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
    Eur J Clin Pharmacol; 2009 Mar; 65(3):263-71. PubMed ID: 18836708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of oxycodone after intravenous injection in adults.
    Pöyhiä R; Olkkola KT; Seppälä T; Kalso E
    Br J Clin Pharmacol; 1991 Oct; 32(4):516-8. PubMed ID: 1958450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?
    Charles B; Hardy J; Anderson H; Tapuni A; George R; Norris R
    Support Care Cancer; 2014 Feb; 22(2):325-30. PubMed ID: 24077699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pooled Post Hoc Analysis of Population Pharmacokinetics of Oxycodone and Acetaminophen Following Multiple Oral Doses of Biphasic Immediate-Release/Extended-Release Oxycodone/Acetaminophen Tablets.
    Morton T; Franke R; Devarakonda K
    Pain Pract; 2016 Jul; 16(6):730-6. PubMed ID: 26218586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biopharmaceutical evaluation of ketoprofen following intravenous, oral, and rectal administration in dogs.
    Schmitt M; Guentert TW
    J Pharm Sci; 1990 Jul; 79(7):614-6. PubMed ID: 2398469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
    Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diclofenac and metabolite pharmacokinetics in children.
    van der Marel CD; Anderson BJ; Rømsing J; Jacqz-Aigrain E; Tibboel D
    Paediatr Anaesth; 2004 Jun; 14(6):443-51. PubMed ID: 15153204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
    Kaiko RF; Benziger DP; Fitzmartin RD; Burke BE; Reder RF; Goldenheim PD
    Clin Pharmacol Ther; 1996 Jan; 59(1):52-61. PubMed ID: 8549034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic disposition of intravenous and oral pentoxifylline in horses.
    Crisman MV; Wilcke JR; Correll LS; Irby MH
    J Vet Pharmacol Ther; 1993 Mar; 16(1):23-31. PubMed ID: 8478997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxycodone pharmacokinetics and fetal exposure after intravenous or epidural administration to the ewe.
    Kinnunen M; Kokki H; Hautajärvi H; Huhta H; Ranta VP; Räsänen J; Voipio HM; Kokki M
    Acta Obstet Gynecol Scand; 2018 Oct; 97(10):1200-1205. PubMed ID: 29772054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, double-blind, placebo-controlled study of the abuse potential of different formulations of oral oxycodone.
    Webster LR; Bath B; Medve RA; Marmon T; Stoddard GJ
    Pain Med; 2012 Jun; 13(6):790-801. PubMed ID: 22568663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and variation in the clearance of oxycodone and hydrocotarnine in patients with cancer pain.
    Kokubun H; Fukawa M; Matoba M; Hoka S; Yamada Y; Yago K
    Biol Pharm Bull; 2007 Nov; 30(11):2173-7. PubMed ID: 17978495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin.
    Kerb R; Brockmöller J; Staffeldt B; Ploch M; Roots I
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2087-93. PubMed ID: 8878586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administration.
    Huupponen R; Paija O; Salonen M; Björklund H; Rouru J; Anttila M
    Drugs R D; 2003; 4(6):339-45. PubMed ID: 14584962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.